Development and implementation of “Check of Medication Appropriateness” (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance

Table 5 Acceptance rate of actions for four pharmacotherapeutic categories performed by electronic notes plus phone calls^f

Category	Total number of patients (n)	Exclusion		Total number of actions (n)	Number of actions accepted by physician (n (%))
Category	Total number of patients (n)	Duplicates	Not possible to verify*	Total number of actions (n)	Number of actions accepted by physician (n (%))
Drug use in renal insufficiency	27	/	5	22	16 (73%)
Drugs with high potential of QTc prolongation	66	/	3	63	48 (76%)
Drugs with restricted indication or dosing	66	/	6	60	44 (73%)
Overruled very severe DDIs	141	46	11	84	81 (96%)
Total	300	71		229	189 (83%)

^fDDI drug-drug interaction, n absolute number. *notes for which the acceptance rate could not be verified because of a discharge or transfer to another hospital unit

ISSN: 1472-6947